Intra-articular injection of mesenchymal stem cells is a potential therapeutic strategy for
cartilage protection and symptom relief for osteoarthritis (OA). However, controlling …

Osteoarthritis (OA) is a chronic and inflammatory disease with no effective regenerative
treatments to date. The therapeutic potential of mesenchymal stem cells (MSCs) remains to …

Icariin, a traditional Chinese medicine, has previously been demonstrated to promote
chondrogenesis of bone marrow mesenchymal stem cells (BMSCs) in traditional 2D cell …

Development of an in situ injectable hydrogel with controlled-release of bioactive molecules
is an effective strategy to maintain chondrocyte phenotype and promote cartilage formation …

Objective Osteoarthritis (OA) is characterized by progressive cartilage degeneration and
absence of curative therapies. Therefore, more efficient therapies are compellingly needed …

Mesenchymal stem cells (MSCs) have been widely investigated to repair injured cartilage
tissues for the treatment of arthritis. Despite these great efforts, the difficulty in the …

Currently, an effective repair method that can promote satisfactory cartilage regeneration is
unavailable for cartilage damages owing to inevitable inflammatory erosion. Cartilage tissue …

Intra-articular injection of adipose mesenchymal stem cells (ADSCs) is a potential alternative
to the treatment of osteoarthritis (OA) and has aroused great interest of clinical researchers …

Objective: Osteoarthritis (OA) is a disease that limits the mobility of patients and is of
considerable economical importance. Up to now, despite the increasing number of patients …

Osteoarthritis (OA) is one of the most common refractory degenerative articular cartilage
diseases. Human amniotic mesenchymal cells (hAMSCs) have emerged as a promising …